Nivaan Care Raises USD 7 Mn in Series A Funding Led by Sorin Investments The round also saw participation from existing investors W Health Ventures, Endiya Partners, and Rebright Partners.

Single-specialty interventional pain management chain Nivaan Care has raised USD 7 million in a Series A funding round led by Sorin Investments.

The round also saw participation from existing investors W Health Ventures, Endiya Partners, and Rebright Partners.

The Delhi-based health-tech startup plans to use the fresh capital to expand its clinic network across multiple Indian cities, strengthen clinical and operational infrastructure, and continue developing minimally invasive pain management procedures.

This funding follows the company's seed round of USD 4.25 million raised in February 2025, which was led by Endiya Partners with participation from W Health Ventures.

Founded in 2023 by Nivesh Khandelwal and Vishwas Singh, Nivaan Care focuses on non-surgical and minimally invasive treatment for chronic pain. The startup operates single-specialty clinics that address conditions such as back, knee, and neck pain through a multidisciplinary care model. Its teams include pain physicians, physiotherapists, psychologists, nutritionists, and care coordinators who work together to deliver personalized treatment plans.

Nivaan Care currently operates clinics across Delhi-NCR and Mumbai, along with satellite markets such as Jaipur and Lucknow. According to the startup, it has completed more than 40,000 patient consultations and around 5,000 minimally invasive procedures so far. A significant proportion of patients have reported noticeable pain reduction and improved daily functioning following treatment.

"Chronic pain affects nearly one in five adults in India, yet care delivery remains fragmented, often oscillating between basic physiotherapy and invasive surgery," said Nivesh Khandelwal, Co-founder and CEO of Nivaan Care. He added, "At Nivaan, we are building a dedicated, evidence-led middle layer of care that focuses on minimally invasive interventions, such as Radiofrequency Ablation and Platelet-Rich Plasma therapy, delivered through a multidisciplinary model."

Vishwas Singh, Co-founder and COO, said, "As we scale, our focus is on execution excellence, strong operating systems, and seamless patient journeys across locations," he said, noting that the company plans to enter new markets including Bengaluru.

The founding team brings prior experience in scaling healthcare and consumer-focused businesses. Khandelwal previously served as chief operating officer at Ridge IVF, while Singh has held leadership roles at companies such as Tata 1mg and Shuttl.